| Literature DB >> 35206778 |
John Bwire Ochola1,2, Clifford Maina Mutero1,3, Rose Muthoni Marubu1, Barbara Frei Haller1,4, Ahmed Hassanali2, Wilber Lwande1.
Abstract
Mosquitoes are vectors of many severe diseases, including malaria, yellow as well as dengue fever, and lymphatic filariasis. The use of synthetic chemical insecticides for mosquito control has been associated with resistance development and detrimental human, and ecological effects. For a safer alternative, the emulsified Ocimum kilimandscharicum oil formulation was evaluated for its larvicidal activity. The oil was analyzed by GC and GC/MS. The formulations were evaluated against third instar mosquito larvae in the laboratory and later compared with Bacillus thuringiensis subsp. israelensis against An. gambiae under field-simulated conditions. Thirty-nine compounds were identified in the oil, the main ones being D-camphor (36.6%) and limonene (18.6%). The formulation showed significant larval mortalities against An. gambiae and An. arabiensis larvae with LC50 of 0.07 and 0.31 ppm, respectively, at 24 h. Under the field-simulated trial, within 24 h, the formulation showed 98% mortality while Bti had achieved 54%. On day three, it caused 100% mortality while Bti achieved 76.5%. The high bioactivity and sublethal toxic effects to offspring of treated mosquito larvae, in terms of disruption of larval morphological aspects, suggest the high potential of the formulation as a botanical larvicide. The formulation, thus, may provide a valuable alternative for the effective and eco-friendly control of disease vectors.Entities:
Keywords: biopesticide; botanical; formulation; larvicide; malaria; mosquito control
Year: 2022 PMID: 35206778 PMCID: PMC8877965 DOI: 10.3390/insects13020203
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Chemical composition of the essential oil of O. kilimandscharicum harvested in the dry season.
| RI | Compounds | Relative Content (%) |
|---|---|---|
| 923 | Tricyclene | 0.71 |
| 931 | 1.94 | |
| 946 | Camphene | 7.14 |
| 989 | Myrcene | 1.88 |
| 1003 | 0.76 | |
| 1008 | 0.68 | |
| 1024 | 0.23 | |
| 1029 | Limonene | 18.61 |
| 1046 | ( | 0.92 |
| 1059 | 1.05 | |
| 1085 | 2.23 | |
| 1093 | 6-Camphenol | 0.6 |
| 1098 | 0.86 | |
| 1100 | Linalool | 4.32 |
| 1143 | Camphor | 36.58 |
| 1158 | Isoborneol | 0.14 |
| 1165 | Borneol | 0.97 |
| 1167 | 3.6 | |
| 1180 | Terpinen-4-ol | 3.9 |
| 1247 | Geranial | 0.21 |
| 1286 | ( | 1.4 |
| 1351 | 0.08 | |
| 1357 | Eugenol | 0.14 |
| 1378 | 0.5 | |
| 1419 | ( | 1.94 |
| 1433 | 1.07 | |
| 1450 | 0.26 | |
| 1455 | 0.38 | |
| 1470 | Bicyclogermacrene | 0.47 |
| 1476 | Geranyl propanoate | 1.28 |
| 1480 | 0.12 | |
| 1482 | Germacrene D | 1.17 |
| 1497 | Viridiflorene | 0.46 |
| 1503 | 0.12 | |
| 1541 | Sesquisabinene hydrate, cis- | 2.12 |
| 1601 | Humulene epoxide II | 0.08 |
| 1700 | Geranyl propanoate | 0.17 |
| 1470 | Dauca-5,8-diene | 0.23 |
Mortality level (%) of 3rd instar mosquito larvae.
| Treatment | Mosquito Species | Time | Concentrations (ppm)/% Mortality | Lethal Concentration | Treatment Response | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Control (-ve)-Water | 0.1 | 0.25 | 0.5 | 1 | LC50 (95%CL) | LC90 (95%CL) | R2 | X2, df, | |||
|
| 24 | 0.0 | 4.7 | 18.2 | 37.1 | 60.0 | 0.74 | 3.45 | 0.9929 | X2 = 1954.00 | |
| 48 | 0.0 | 20.4 | 43.6 | 63.4 | 100.0 | 0.31 | 1.82 | 0.9786 | X2 = 2025.06 | ||
|
|
| 24 | 0.0 | 34.2 | 67.2 | 75.9 | 99.4 | 0.07 | 2.39 | 0.794 | X2 = 1923.69 |
| 48 | 0.0 | 21.0 | 94.0 | 99.9 | 100.0 | 0.14 | 0.22 | 0.9394 | X2 = 794.00, | ||
|
| 24 | 0.0 | 29.9 | 46.2 | 59.0 | 71.0 | 0.31 | 4.72 | 0.87635 | X2 = 4688.80 | |
| 48 | 0.0 | 43.2 | 62.1 | 74.8 | 84.8 | 0.14 | 1.63 | 0.8394 | X2 = 3052.08 | ||
| Emulsion/surfactant (Tween 80) |
| 24 | 0.0 | 0.4 | 1.1 | 2.3 | 4.3 | 75.28 | 1877.55 | 0.9978 | X2 = 47.97 |
| 48 | 0.0 | 0.9 | 2.3 | 4.3 | 7.7 | 30.162 | 648.88 | 0.9973 | X2 = 75.11 | ||
|
| 24 | 0.0 | 1.3 | 2.6 | 4.1 | 6.3 | 172.57 | 12,795.98 | 0.9694 | X2 = 111.91 | |
| 48 | 0.0 | 1.6 | 3.6 | 6.1 | 9.9 | 31.99 | 1011.90 | 0.9847 | X2 = 142.31 | ||
LC50 = Mean lethal concentration, 95% CL = upper/lower confidence Interval. Comparison of LC50 and LC90 values based on confidential limits in case C.L. Overlap showed no significant differences at p < 0.05. The emulsified O. kilimandscharicum oil formulation showed comparable levels of activity against third instar larvae of An. gambiae and An. arabiensis, as shown in Table 3. Compared to negative controls, the LC50 for emulsified O. kilimandscharicum oil formulation was the lowest and substantially reduced survival rates of An. gambiae and An. arabiensis. The LC50 for the formulation was highest against An. gambiae larvae. There was considerable vulnerability variation amongst the two mosquito species to the formulation based on the degree of overlap of fiducial limits (FL/CL, α = 0.05, p = 0.05).
Effect of larval exposure to sublethal doses of emulsified O. kilimandscharicum oil formulation.
| Treatment |
|
| ||
|---|---|---|---|---|
| Mean No of Pupae (M ± SE) | Mean No of Adults (M ± SE) | Mean No of Pupae (M ± SE) | Mean No of Adults (M ± SE) | |
| LC70 | 31.3 ± 1.68 a | 29.0 ± 2.3 a | 32.0 ± 1.15 a | 22.3 ± 1.28 a |
| LC50 | 49.7 ±1.68 b | 44.7 ± 2.3 b | 45.0 ± 1.15 b | 39.0 ± 1.28 b |
| LC20 | 71.3 ± 1.68 c | 67.0 ± 2.3 c | 65.0 ± 1.15 c | 62.3 ± 1.28 c |
| Control | 79.0 ± 1.68 d | 75.3 ± 2.3 d | 73.0 ± 1.15 d | 68.0 ± 1.28 c |
Number (mean ± SE) of pupae and adults emerged from 100 larvae exposed to sublethal doses of emulsified O. kilimandscharicum oil formulation. Means followed by the same letter are not significantly different in a Tukey test, at p < 0.05.
Figure 1Effect of sub-lethal dose of emulsified O. kilimandscharicum oil formulation on mosquito larval development, pupation, and adult stage. (a) Normal An. gambiae s.s. (b) Demelanized An. gambiae s.s larval-pupal intermediate. (c) Abnormal An. gambiae s.s larval–pupal intermediate. (d) Arrested adult emergence in An.gambiae. (e) Abnormal An. arabiensis larvae in negative control solution. (f) A stunted An. arabiensis larval–pupal intermediate. (g) Abnormal An. arabiensis larval–pupal intermediate. (h) Failed adult emergence in An. Arabiensis.
Figure 2Larvicidal activity under field-simulated conditions in Kilifi of emulsified O. kilimandscharicum oil formulation and Bti granules.